LEBOVITS CHAIM (See Remarks) received a stock award from BRAINSTORM CELL THERAPEUTICS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/7/2024ACC: 0001104659-24-057784
Officer· See Remarks
Since Jul 2018
+135K
Net shares
Net buyer
$50.7K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
135K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+135K
Price / share
$0.38
Trade value
$50.67K
% of position
15.7%
5/6/2024
858.57K→993.57K
Total
Net shares
+135K
Net value
$50.67K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/6/2024 | A · Award | +135K | $0.38 | $50.67K | 15.7% | 858.57K | 993.57K |
| Total | +135K | $50.67K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned2M
Total
2M indirect2M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2M | Indirect |
| Total | 2M | 2M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported